Key facts
- Notable investors include Genesis Pre-Seed Fund.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Gallant Bio Tech
- ·The full record, as it builds
Funding rounds
No funding rounds for Gallant Bio Tech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gallant Bio Tech
Provider and developer of testing and developing services designed for traditional medicine. The company focuses on evaluation of traditional medicine and products with effective drug ingredients, enabling clients with testing services.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Hong Kong, Hong Kong
- Founded
- 2013
- Website
- gallantbiotech.com/
- Ownership
- Privately Held (backing)
Gallant Bio Tech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gallant Bio Tech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gallant Bio Tech in its N-PORT filings yet. We sweep new filings monthly.